A. W. Chan, K. Y. Chong, C. Martinovich, C. Simerly, and G. Schatten, Transgenic monkeys produced by retroviral gene transfer into mature oocytes, Science, vol.291, pp.309-312, 2001.

S. H. Yang, Towards a transgenic model of Huntington's disease in a nonhuman primate, Nature, vol.453, pp.921-924, 2008.

W. J. Bowers, X. O. Breakefield, and M. Sena-esteves, Genetic therapy for the nervous system, Hum Mol Genet, vol.20, pp.28-41, 2011.

K. D. Foust, Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes, Nat Biotechnol, vol.27, pp.59-65, 2009.

H. Zhang, Several rAAV vectors efficiently cross the blood-brain barrier and transduce neurons and astrocytes in the neonatal mouse central nervous system, Mol Ther, vol.19, pp.1440-1448, 2011.

C. N. Cearley and J. H. Wolfe, Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain, Mol Ther, vol.13, pp.528-537, 2006.

S. Duque, Intravenous administration of self-complementary AAV9 enables transgene delivery to adult motor neurons, Mol Ther, vol.17, pp.1187-1196, 2009.

K. D. Foust, Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN, Nat Biotechnol, vol.28, pp.271-274, 2010.

E. Dominguez, Intravenous scAAV9 delivery of a codon-optimized SMN1 sequence rescues SMA mice, Hum Mol Genet, vol.20, pp.681-693, 2011.

C. Spampanato, Efficacy of a combined intracerebral and systemic gene delivery approach for the treatment of a severe lysosomal storage disorder, Mol Ther, vol.19, pp.860-869, 2011.

A. Kamiya, Animal models for schizophrenia via in utero gene transfer: understanding roles for genetic susceptibility factors in brain development, Prog Brain Res, vol.179, pp.9-15, 2009.

A. A. Rahim, Intravenous administration of AAV2/9 to the fetal and neonatal mouse leads to differential targeting of CNS cell types and extensive transduction of the nervous system, FASEB J, vol.25, pp.3505-3518, 2011.

S. J. Gray, Directed evolution of a novel adeno-associated virus (AAV) vector that crosses the seizure-compromised blood-brain barrier (BBB), Mol Ther, vol.18, pp.570-578, 2010.

N. Maheshri, J. T. Koerber, B. K. Kaspar, and D. V. Schaffer, Directed evolution of adeno-associated virus yields enhanced gene delivery vectors, Nat Biotechnol, vol.24, pp.198-204, 2006.

S. Fasano, Inhibition of Ras-guanine nucleotide-releasing factor 1 (Ras-GRF1) signaling in the striatum reverts motor symptoms associated with L-dopa-induced dyskinesia, Proc Natl Acad Sci U S A, vol.107, pp.21824-21829, 2010.
URL : https://hal.archives-ouvertes.fr/hal-01055134